Introduction: Coronavirus disease-2019 (COVID-19) is a global pandemic without any specific treatment to date. Drug utilisation plays a vital role in helping the health care system to understand the pattern of drug use. Aim: To assess the prescribing trends among COVID-19 patients admitted to the hospital. Methodology: This was a retrospective cohort study conducted at a tertiary hospital dedicated to COVID-19 patients. Patients admitted in AIIMS, Patna from March 2020 to October 2020 were analyzed for WHO core prescribing indicators and was compared with the standard WHO values. Results: The median value of drugs prescribed was found to be 7 (IQR-6-8). The most common drugs prescribed for COVID-19 were Azithromycin (25.95%), hydroxychloroquine (23.88%) followed by paracetamol (20.17%) and Heparin (16.35%). The percentage of drugs prescribed by generic name was 77.72%. The average number of drugs from NLEM was 92.56%. Drugs were classified based on the Anatomical Therapeutic and Chemical Classification (ATC) and the majority of the drugs belonged to the J category which is the anti-infective group of drugs. The defined daily dose (DDD) /100 bed-days of azithromycin and cefixime was 5.2 and 0.092, respectively. Conclusion: Polypharmacy being the common finding, the concept of generic prescribing was practised well. There was a lesser number of prescriptions containing drugs from the National List of Essential Medicines, and the number of prescriptions containing antibiotics and injections was following criteria. The WHO prescribing criteria were met with moderate adherence.